Create Alert
Watchlist
₹0.00
0.00 (0.00%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
0.00
Prev. Close
0.00
Volume
NA
Total traded value
NA
Upper Circuit
NA
Lower Circuit
NA

Fundamentals

Market Cap₹46,566Cr
ROE4.68%
P/E Ratio(TTM)120.94
EPS(TTM)2.88
P/B Ratio1.78
Dividend Yield0.13%
Industry P/E34.34
Book Value195.54
Debt to Equity0.85
Face Value5
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Biocon

Biocon Limited is an India-based biopharmaceutical company, which focuses on treating diabetes, cancer and autoimmune diseases. Its segment includes Generics, Biosimilars, Novel Biologics and Research Services. It has developed and commercialized novel biologics, biosimilars, and complex small molecule active pharmaceutical ingredients (APIs) in India and several key global markets, as well as Generic Formulations in the United Sates, Europe and key emerging markets. Its API portfolio includes cardiology, anti-diabetics, immunosuppressants, multiple sclerosis, anti-cancer/oncology and other key products. Its products include Tacrolimus, Rosuvastatin, Simvastatin, Atorvastatin, Pravastatin, Fingolimod and others. It has over five facilities across Bangalore, Hyderabad and Visakhapatnam in India. Its API manufacturing facilities leverage complex technology platforms that range from microbial fermentation, chromatographic purification, chemical synthesis, peptide synthesis and HPAPIs.;
Parent OrganisationBiocon Limited
Managing DirectorMr. Siddharth Mittal
NSE SymbolBIOCON

Shareholding Pattern

Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Promoters
54.45%
Retail And Others
16.68%
Mutual Funds
15.24%
Other Domestic Institutions
7.59%
Foreign Institutions
6.04%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Anthem Biosciences
NA
(0.00%)
101.81
Onesource Specialty Pharma
NA
(0.00%)
-1713.45
Advanced Enzyme Technologies
NA
(0.00%)
28.28
Panacea Biotec
NA
(0.00%)
229.17